 |
|
DNA replication behavior in complex organisms may foreshadow leaps in genomic discoveries
August 16, 2007For the first time, findings by scientists at the Genome Institute of Singapore (GIS) may be paving the way for more efficient analyses and tests related to the replication of cells, and ultimately, to the better understanding of human biology, such as in stem cell research.
Faithful duplication of the genome (the hereditary information that is encoded in genetic materials known as DNA) ensures that daughter cells inherit a complete set of genetic materials identical to parent cells. This duplication occurs in the section of the cell cycle known as the S-phase. Extensive research on the budding yeast, an organism often used in modern cell biology research, had revealed that the replication process is initiated at hundreds of origins in the S-phase. However, because previous studies focused on the replication timing and initiation sites, but not on the efficiency, it was thought that replication efficiency decreased as the S-phase progressed.
In a paper published in PLoS ONE in August 2007, GIS scientists described how they were able to determine the replication timing and efficiency at the various loci in the genome. Specifically, replication efficiency was found to be low at the beginning of the S-phase, and increased at the later stage of this phase.
GIS Group Leader and the corresponding author of the publication, Dr Liu Jianhua, said, "Our evidence strongly supports the stochastic model for the regulation of DNA replication in high eukaryotes (organisms whose cells are organised into complex structures by internal membranes and a cytoskeleton) such as humans. We have shown that replication efficiency can be directly determined on a genomic scale. More significantly, our study provides for a novel methodology for the analysis of replication efficiencies at a genomic level in other species, and this is a very important step for the advancement of research in fundamental biology."
Public Library of Science
GIS Group Leader and the corresponding author of the publication, Dr Liu Jianhua, said, "Our evidence strongly supports the stochastic model for the regulation of DNA replication in high eukaryotes (organisms whose cells are organised into complex structures by internal membranes and a cytoskeleton) such as humans. We have shown that replication efficiency can be directly determined on a genomic scale. More significantly, our study provides for a novel methodology for the analysis of replication efficiencies at a genomic level in other species, and this is a very important step for the advancement of research in fundamental biology."
Public Library of Science
New drug aims to 'seek and destroy' many types of cancer
A new drug designed to "seek and destroy" common cancers such as breast, prostate, endometrial, pancreatic, ovarian, skin and testicular cancers is being tested at TGen Clinical Research Services (TCRS) at Scottsdale Healthcare.
More Genomic Discoveries Current Events and Genomic Discoveries News Articles
 |
Genomics in Drug Discovery and Development by Dimitri Semizarov (Author), Eric Blomme (Author) Early characterization of toxicity and efficacy would significantly impact the overall productivity of pharmaceutical R&D and reduce drug candidate attrition and failure. By describing the available platforms and weighing their relative advantages and disadvantages, including microarray data analysis, Genomics in Drug Discovery and Development introduces readers to the biomarker, pharmacogenomic, and toxicogenomics toolbox. The authors provide a valuable resource for pharmaceutical discovery scientists, preclinical drug safety department personnel, regulatory personnel, discovery toxicologists, and safety scientists, drug development professionals, and pharmaceutical scientists. |
|
Bioinformatics-methods and Applications: Genomics, Proteomics and Drug Discovery by S.C. Rastogi (Author), N. Mendiratta (Author), P. Rastogi (Author) | |
 |
Microbial Genomics and Drug Discovery by Thomas J. Dougherty (Editor), Steven J. Projan (Editor) Examines bioinformatic and genomic approaches for the identification, detection, selection, and validation of new antibacterial targets and vaccine candidates. Explores potential pathways for effective infection control, inhibition of antibacterial resistance, and acceleration of drug discovery processes. Illustrates the use of Pathway Tools in a genomics-based drug discovery project. |
 |
Integrated Genomics: A Discovery-Based Laboratory Course by Guy A. Caldwell (Author), Shelli N. Williams (Author), Kim A. Caldwell (Author) Integrated Genomics: A Discovery-Based Laboratory Course introduces the excitement of discovery to the basic molecular biology laboratory. Utilizing up-to-date molecular biology protocols and a basic experimental design, this text offers experience with three different model systems. Students will become familiar with the simplicity and power of single-celled organisms, Escherichia coli and Saccharomyces cerevisiae, as they search for genes that interact and function within the nematode Caenorhabditis elegans. Incorporated throughout the course are exercises designed to offer students familiarity with the wealth of bioinformatics data that can be accessed on the World Wide Web. Following completion of interaction studies within the yeast, the course is designed to allow students... |
 |
Genomics in Cancer Drug Discovery and Development, Volume 96 (Advances in Cancer Research) by Garret Hampton (Editor), Karol Sikora (Editor), George F. Vande Woude (Editor), George Klein (Editor) The Advances in Cancer Research series provides invaluable information on the exciting and fast-moving field of cancer research. This volume stands as the first ever thematic volume in the series, focusing on the topic of genomics in cancer drug development. The chapters included in this book represent the cutting-edge information in the field and span such topics as Mass Spectrometry: Uncovering the Cancer Proteome for Diagnostics; Biomarker Discovery in Epithelial Ovarian Cancer by Genomic Approaches; The Application of siRNA Technology to Cancer Biology Discovery; Ribozyme Technology for Cancer Gene Target Identification and Validation; Cancer Cell-Based Genomic and Small Molecule Screens; Tumour Antigens as Surrogate Markers and Targets for Therapy and Vaccines; Practices and Pitfalls... |
 |
Modern Methods of Drug Discovery by Alexander Hillisch (Editor), R. Hilgenfeld (Editor) This volume offers a broad and interdisciplinary view of modern approaches to drug discovery as used by pharmaceutical companies and research institutes. It comprehensively covers proteomics, bioinformatics, screening techniques such as high-throughput-, natural compounds-, and NMR-based-screenings, combinatorial chemistry, compound library design, ligand- and structure-based drug design and pharmacokinetic approaches. Each of the thirteen chapters reviews the theory, background and application of a key technology in drug discovery and is complemented by an extensive list of references to the original literature. This concise source of information will be useful for researchers, both in industry and academia, as well as students in the fields of medicinal, pharmaceutical and... |
 |
Drug Discovery Research: New Frontiers in the Post-Genomic Era by Ziwei Huang (Author) Post Genomics Drug Discovery and Research explores and discusses some of the most important topics in post-genomics life and biopharmaceutical sciences. It provides an introduction to the field, outlining examples of many techniques currently used, as well as those still under development, which are important for the research of biopharmaceutical discovery in the post-genomics era. Integrates several developing and cutting-edge technologies and methods like bioinformatics, experimental therapeutics, and molecular recognition Includes discussion on topics such as: computer-aided ligand design; peptide and protein chemistry and synthesis; synthesis of active natural products; and the use of emerging technologies like proteomics, nanotechnology, or bioengineering. ... |
 |
Applying Genomic and Proteomic Microarray Technology in Drug Discovery by Robert S. Matson (Author) Microarray technology, more commonly known as small spots, has proved a success when employed in DNA array-based genomic analysis. It is now beginning to be employed in protein tissue array analysis; and as microarray continues to be adopted it is important that researchers grasp the fundamental principles behind it, as well as, the strengths and limitations. This highly informative book written by an leader in the field introduces the fundamentals of microarray technology, it then goes on to describe and evaluate the use of microarray technology in genomic and proteomic applications, and provide practical tips on how to employ the technology in drug discovery and development. |
|
Orion obtains patent covering genome-wide biomarker discovery platform.(Orion Genomics L.L.C.): An article from: BIOTECH Patent News by Gale Reference Team (Author) This digital document is an article from BIOTECH Patent News, published by Thomson Gale on November 1, 2006. The length of the article is 552 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Orion obtains patent covering genome-wide biomarker discovery platform.(Orion Genomics L.L.C.) Author: Gale Reference Team Publication: BIOTECH Patent News (Newsletter) Date: November 1, 2006 Publisher: Thomson Gale Volume: 20 Issue: 11 Distributed by Thomson... | |
 |
Text Mining for Genomics-based Drug Discovery by Patrick Herron (Author) While many text mining projects emphasize retrieval and extraction, text mining can be leveraged to discover new and previously unknown information. Nowhere is the potential more apparent than in pharmacogenomics-based drug discovery. Text mining can help pharmaceutical researchers reduce the vast information overload hindering pharmacogenomics-based drug discovery because it can aid in the generation of rich novel information from large collections of diverse scientific literature and research data. However the pharmaceutical industry appears to be reluctant to innovate bleeding-edge text mining technologies for drug discovery. The present book re-frames text mining as an approach to automate the generation of novel and interesting information, reviews successful exemplary text mining... |
| © 2009 BrightSurf.com |